Related Experiment Video
Updated: Sep 15, 2025

09:22
In Vitro Aggregation Assays Using Hyperphosphorylated Tau Protein
Published on: January 2, 2015
18.5K
Structure-specific Mini-Prion Model for Alzheimer's Disease Tau Fibrils
Vishnu Vijayan1, Gregory E Merz2,3, Karen Tsay1
1Department of Chemistry and Biochemistry, University of California, Santa Barbara, Santa Barbara, CA, USA.
Biorxiv : the Preprint Server for Biology
|July 16, 2025
Summary
Researchers designed synthetic tau protein fibrils that mimic disease structures found in Alzheimer's Disease (AD) and Chronic Traumatic Encephalopathy (CTE). These mini-prions efficiently seed tau aggregation, offering a new strategy for developing diagnostics and therapeutics for tauopathies.
Area of Science:
- Neuroscience
- Biochemistry
- Structural Biology
Background:
- Tau protein fibrils adopt disease-specific structures in various tauopathies.
- Generating synthetic fibrils with hallmark structures is crucial for developing diagnostics and therapeutics.
- Alzheimer's Disease (AD) and Chronic Traumatic Encephalopathy (CTE) are major tauopathies.
Purpose of the Study:
- To rationally design synthetic tau fibrils that mimic disease-specific structural motifs.
- To investigate the seeding competency and templating capabilities of these synthetic fibrils.
- To establish a novel strategy for creating pathological tau fibril models.
Main Methods:
- Rational design of short peptides to adopt critical structural motifs of tauopathy fibrils.
- In vitro and cell-based seeding assays using tau biosensor cells.
- Double Electron-Electron Resonance (DEER) studies to confirm structural preservation across seeding generations.
Main Results:
- Developed synthetic mini-prions with exquisite seeding competency for tau constructs.
- Demonstrated that mini-AD prions catalyze the generation of AD and CTE-like fibril structures.
- Confirmed structural preservation of AD-like folds across multiple seeding generations via DEER.
- Showcased the dominance of templating effects over salt composition in fibril formation.
Conclusions:
- Mini-AD prions serve as potent catalysts with templating capabilities for generating pathological tau fibril models.
- This approach offers a novel strategy for designing synthetic tau fibrils that mimic disease-specific structures.
- The developed synthetic fibrils can serve as targets for diagnostic and therapeutic strategies in tauopathies.
Related Concept Videos
Amyloid Fibrils
9.9K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.9K
Alzheimer's Disease: Overview
673
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
673

